US judge limits access to abortion pills

The future of abortion access in the United States is uncertain after a US District Judge blocked the FDA’s approval of mifepristone, one of the two medications used in a medication abortion. 

Abortion medication is still available. The ruling is expected to go into effect on April 14, and would suspend the FDA approval of mifepristone nationwide, but the Department of Justice has appealed.

A competing ruling, in Washington State, ordered the FDA to maintain the status quo on mifepristone in 17 states. The case is likely to reach the Supreme Court.

Demand for safe abortion care has increased in the states where it is legal since the overturning of Roe v. Wade last summer. But on April 7, US District Judge Matthew Kacsmaryk, an appointee of former President Donald Trump with no medical credentials, overturned the US Food and Drug Administration (FDA)’s approval of the most commonly used abortion drug, mifepristone.

Mifepristone has been approved for more than 20 years. It is so safe and effective that the FDA had recently removed restrictions on its use, citing a recent study which used data from research conducted by MSI in the United Kingdom.  

An MSI provider shows a pack of abortion medications. The large pill is mifepristone; the four smaller pills are misoprostol. Together, they are more than 99% effective at ending a pregnancy.

Medication abortion is safe and effective  

Medication abortion has become an increasingly popular option for women in the early stages of pregnancy, both here in the United States and around the world. Instead of waiting for a medical procedure, women simply take two pills before the 10th week of their pregnancy.  

In the US, the first pill, mifepristone is generally taken under the supervision of a doctor in a clinic. During Covid, that requirement was relaxed and both it and misoprostol, a second medication taken up to 48 hours later, were taken at home.  In other parts of the world, both pills have been taken at home without risk for years.   

Medication abortion is very safe, with extremely low rates of complication whether taken in a facility or at home. At MSI, we provide medication abortion both in-facility and in women’s homes, depending on local policies. About 60% of our abortion clients chose medication abortion with mifepristone and misoprostol. 

Standing up to anti-choice restrictions 

While abortion can be safely and effectively completed using just misoprostol, this decision subverts the Food and Drug Administration’s authority, restricting access to mifepristone even in states where abortion is still legal. MSI’s global medical director, Dhammika Perera, said:  

“Be under no illusion, Roe v Wade was not the endpoint, it was just the beginning. As the organized rollback of reproductive healthcare and women’s rights continues in the US, we urge the Biden administration to act decisively and appeal this dangerous decision.”   

Our experience around the world shows that medication abortion is preferred by many clients and is proven to be safe and effective. That’s why we’ll keep working to ensure this option is available to the women we serve.  


Real people, real stories, real solutions.

21 million futures transformed in 2022

In 2022, MSI saw unprecedented demand for sexual and reproductive health… Read More

How MSI teams navigate climate change

In the face of the climate crisis, women need control… Read More

Self-care in a crisis 

In a humanitarian crisis—such as an armed conflict, natural disaster, or… Read More

View All